Aspirin-COVID-19: A new study led by researchers from University of Maryland School of Medicine (UMSOM) shows that hospitalized COVID-19 patients who were taking a daily low-dose aspirin to protect against cardiovascular disease had a significantly lower risk of complications and death compared to those who were not taking aspirin.
Importantly, aspirin takers were less likely to be placed...
POST COVID: A new study by researchers from Imperial College London-UK, University of Southampton-UK, University of Cambridge-UK and King’s College London-UK and University of Chicago-USA has reported concerning findings showing that patients who had recovered from COVID-19 exhibited significant cognitive deficits.
Numerous past studies have revealed neurological problems in severel...
Source: United States-COVID-19 Oct 24, 2020 3 years ago
United States-COVID-19: America reported a record of more than 81,000 new COVID-19 infections over the last 24 hours according to figures from Worldometer.
It was reported that between 8:30 pm Thursday and the same time Friday, 81,210 infections were recorded, bringing the total number since the start of the pandemic to nearly 8.5 million COVID-19 infected cases in the country w...
Source: COVID-19 Supplements Oct 24, 2020 3 years ago
COVID-19 Supplements: A new study by researchers from the Institute for Optimum Nutrition-UK, University of Otago-New Zealand, Swansea University Medical School-UK, Morriston Hospital-UK Eastern, Virginia Medical School-USA and University of Oxford-UK demonstrates that Vitamin C can be used as an adjuvant to treat COVID-19 especially in the severe and critical stages.
Ascorbic acid or vit...
Source: COVID-19 -Dexamethasone Oct 24, 2020 3 years ago
COVID-19 -Dexamethasone: A new study led by researchers from University of Virginia-U.S. along with scientist from Polish Academy of Sciences-Poland, Poznan University of Technology-Poland, Medical University of Bialystok-Poland and University of South Carolina-U.S. has discovered a about how the human body transports dexamethasone, a drug that can increase the survival chances of patients wi...
Source: Convalescent Plasma Oct 23, 2020 3 years ago
Convalescent Plasma: An open label phase II multicenter randomized controlled trial (PLACID Trial) of convalescent plasma in the management of moderate COVID-19 in 464 adults in India has showed that the treatment protocol does not does not reduce their chances of getting seriously ill or dying, in simple words, it is not effective in treating COVID-19.
The study findings were publis...
Source: COVID-19 Infections Oct 23, 2020 3 years ago
Editorial:
COVID-19 Infections: A new record high of 478,065 COVID-19 infections was recorded in the last 24 hours with just a mere 6,740 deaths. (Source: Worldometer)
However despite the mediocre death rates, the rising new COVID-19 infections are a good sign as it shows that the second wave is truly coming and more are expected to die.
Now some might wonder as to why a med...
COVID-19 Updates: A new study by researchers from Massachusetts General Hospital, Icahn School of Medicine, Cohen Children's Medical Center, University of California-San Francisco, Hutchinson Cancer Research Center, University of Pennsylvania and Zucker School of Medicine at Hofstra-Northwell, Hempstead has shown that contrary what was earlier assumed, may severe COVID-19 patients do not...
America Latest: America is facing a major health crisis with the Trump Administration in power and the degree of incompetency, greed and corruption in play. Already America has a total of more than 8.4 million confirmed COVID-19 cases with realistic figures expected to be much higher due to under-reporting in Republican controlled states and lack of testing among asymptomatic cases and as of today...
Virus News: Alarmingly three documented case studies have emerged of individuals developing Parkinson's-like symptoms in the weeks following infection with SARS-CoV-2, the virus that causes COVID-19.
Initially thought to be rare, there are now growing cases being reported by clinicians in Italy, UK, Germany and United States with more researchers and physicians paying more a...
COVID-19-News: Researchers from Semmelweis University and Pazmany Peter Catholic University in Budapest-Hungary, in a news study shows and echoes the same hypothesis that Thailand Medical News has been stating since the start of the pandemic: COVID-19 disease progression and severity and even Post-COVID-19 effects are all dictated by the various mutated strains and variants of the SARS-CoV-2 coron...
Drugs-COVID-19: Fortunately another COVID-19 drug scam is being prevented after the remdesivir saga thanks to honest and credible researchers that cannot be manipulated by money. The US FDA under the Trump administration and Trump’s family and cronies has done even damage with hydrochloroquine and remdesivir issues with many American lives lost and hopefully after Trump loses this elections,...
COVID-19 Scams: Associate Editor at the British Medical Journal (BMJ) Professor Dr Peter Doshi, in a daring but truthful revelation yesterday warned that vaccine trials currently underway are not designed to tell us if they will save lives.
https://www.bmj.com/content/371/bmj.m4037
Although several COVID-19 vaccine trials are now in their most advanced phase 3 stage, but what will i...
Vaccine News: Brazil's health authority Anvisa reported that Brazilian volunteer participating in clinical trials of the COVID-19 vaccine developed by Oxford University and AstraZeneca has died on the 18th of October.
It was unclear whether the volunteer had received the vaccine or a placebo and in countries like Brazil, the organizers can easily switch the facts in or...
Source: Food and Nutrition Oct 21, 2020 3 years ago
Food-Nutrition: Dutch researchers from University of Twente-Netherlands led by pediatrician Dr Ellen van der Gaag in a news study on the effect of unprocessed, pure food on children's health, specifically on the common cold and other upper respiratory tract infections have also discovered certain foods that can help prevent respiratory tract infections.
The study findings were publish...
COVID-19 Spread: Brazilian researchers have developed a new model that predicts spatial and temporal evolution of epidemic diseases and can help plan more effective social isolation programs with less socio-economic impact. The new research study proposes an epidemiological model that provides a more detailed description of how the SARS-CoV-2 coronavirus that causes the COVID-19 diseas...
Source: Precision Epidemiology Oct 21, 2020 3 years ago
Precision Epidemiology: Finally more and more researchers are waking up to fact that COVID-19 cannot be treated in a broad spectrum manner as a personalized or precision medicine approach has to be undertaken to treat every individual as there are so many factors at play including the human host genes and variants from one person to the next coupled with fact that even strains of the virus that ar...
Source: COVID-19 Diagnostics Oct 21, 2020 3 years ago
COVID-19 Diagnostics: Siemens Healthineers has introduced the CLINITEST Rapid COVID-19 Antigen Test that helps identify SARS-CoV-2 infected individuals in 15 minutes so they can isolate sooner and avoid spreading COVID-19.
The easy-to-use test, which doesn't require specialized laboratory personnel or instruments, offers flexibility to test in locations that benefit from immediate results
&nb...
Source: Antibodies COVID-19 Oct 21, 2020 3 years ago
Antibodies COVID-19: A Canadian study last month led by by Université de Montréal professor Dr Andrés Finzi, holder of a Canada Research Chair in Retroviral Entry, and Dr Renée Bazin, director of innovation at Héma-Québec, showed that the neutralization capacity of antibodies produced by a SARS-CoV-2 infected person declined after six weeks, as the person ...
COVID-19 Updates: A breakthrough international research led by scientist from University of Bristol-UK along with experts from University of Queensland –Australia, University of Tartu-Estonia, University of Zurich-Switzerland, Biological Research Centre (BRC), Szeged-Hungary, University of Helsinki-Finland, Institute of Biochemistry-Switzerland, University of Liverpool-UK and Singapore Immun...
Source: Canada COVID-19 Updates Oct 20, 2020 3 years ago
Canada COVID-19 Updates: A more aggressive second wave of COVID-19 has hit Canada with total infected cases now topping over 200,000 COVID-19 cases and is nearing to 10,000 deaths according to official COVID-19 data compiled by Canadian broadcasters CBC and CTV.
What is also more concerning is that a few of the SARS-CoV-2 antibody resistant strains and also more aggressive and infec...
Source: COVID-19 Clinical Care Oct 20, 2020 3 years ago
COVID-19 Clinical Care: Researchers from the department of Genetics, University of Georgia-U.S. and Shanghai Jiao Tong University School of Medicine, Shanghai-China in a collaborative study have discovered a correlation between the white blood cell count and COVID-19 disease severity. The white blood cells are a critical component of the body’s immune system that helps fight infections.
&n...
COVID-19 Drugs: Ensifentrine a drug originally developed by UK based pharmaceutical cum biotech company Verona Pharma to treat chronic obstructive pulmonary disease or COPD could be a new treatment option for hospitalized COVID-19 patients. According to research this dual bronchodilator and anti-inflammatory drug be safe and effective in COVID-19 patients experiencing the debilitating effects of s...
U.S. COVID-19 Updates: America is facing a new surge in COVID-19 cases and the coming winter season will see a catastrophic scenario never seen in its history where it is projected that millions more of Americans will contract the SARS-CoV-2 while hundreds of thousands will be severely ill and will ultimately die.
To date more than 220,180 Americans had died from the COVID-19 disease whil...
Post COVID-19: Researchers from University of Oxford in a new study looking at the longer-term impact of COVID-19 has found that a large proportion of COVID-19 patients discharged from hospital were still experiencing symptoms of breathlessness, fatigue, anxiety and depression two to three months after contracting the virus.
The study team carrying out the C-MORE study has also detected a...
Research News: A study team from the Scripps Research Institute, La Jolla-California led by Dr Taishi Kimura, Ph.D., postdoctoral research associate and first author of the study has uncovered an important disease-fighting role for cells called hepatocytes, which constitute most of the liver. It was found that hepatocytes help control infections from common viruses called coxsackieviruses, and pro...
HIV News: University of British Columbia researchers have concluded a new study of which the findings are set to change international treatment recommendations for individuals who are newly diagnosed with HIV, an update that could affect nearly two million people per year worldwide.
The research found that the antiviral dolutegravir is the optimal medication for first-line treatment for i...
Source: COVID-19 Questions Oct 19, 2020 3 years ago
COVID-19 Questions: In the last few days as we were perusing more studies and emerging data, some things really are not adding up and perhaps some other media, researchers or experts can help us with a few answers please.
First, a study dated 2008 makes mention of SARS-CoV-2 and even of a SARS-CoV-3 and this study though was conducted by Chinese researchers in Beijing was catalogued by th...
NEURO-COVID: A new study led by researchers from New York University Langone Health/NYU School of Medicine along with scientists from John Hopkins and University of Utah have found that about one in seven COVID-19 patients has potentially damaging neurological injuries.
It was found that these neurological injuries range from temporary confusion resulting from low body-oxygen levels ...
COVID-19-News: Researchers from IBM Research at T.J. Watson Research Center-New York, have in a new study found that heteroplasmy was more common in COVID-19 patients that actually thought. Heteroplasmy is a condition when a COVID-19 patient is co-infected with more than one variant or lineage of the SARS-CoV-2 coronavirus. The implications from this study finding are massive in terms of treatment...
Source: COVID-19 Research Oct 19, 2020 3 years ago
COVID-19 Research: A new study by researchers from John Hopkins involving young obese mice has found that obesity typically leads to upregulation of ACE2 receptor expression especially in the lungs and trachea, increasing the risk factor for SARS-CoV-2 infection and severity.
In the study, the researchers demonstrated that:
-a) Ace2 expression is elevated in the lung and trach...
Virus News: A frequent medical question since the last century has been why are some individuals more resilient to viruses than others? Possible answers to that question has eluded researchers and scientists for centuries and, in the age of COVID-19, has come to represent one of the holy grails of biomedical research.
Dr Ed Chuong, an assistant professor of molecular, cellular and develop...
Source: Antibodies-COVID-19 Oct 18, 2020 3 years ago
Antibodies-COVID-19: A new unbiased study by researchers from the University of Montreal has shown that antibody levels drop rapidly in recovering COVID-19 patients.
The study team performed repeated analyses at 1-month intervals on 31 convalescent individuals to evaluate how the humoral responses against the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Spike glycoprotein,...
COVID-19 Latest: Researchers from John Hopkins have identified a compound known as factor D Inhibitor(ACH-145951) that can inhibit the alternative complement immune pathway system that is activated by the SARS-CoV-2 spike protein. Blocking this immune system pathway may stop COVID-19 Infection and prevent severe organ damage.
Animal models demonstrating end-organ protection in C...
COVID-19 News: Researchers from University of Pittsburgh, Cedars-Sinai Medical Center-Los Angeles and Martin Luther University Halle-Wittenberg-Germany have in a new study discovered that a mutation strain of the SAR-CoV-2 called D839Y/N/E that has a unique superantigenic insert in the spike region and is able to generate a hyperinflammatory syndrome reminiscent of toxic shock syndrome (TSS)&...
COVID-19-Infants: French researchers from the Division of Pediatrics and Neonatal Critical Care at “A.Béclère” Medical Centre, Paris Saclay University Hospitals have in a new meta-analysis study involving 176 case reports and past studies found that up to 30 percent of all COVID-19 infected infants had contracted the virus from their mothers.
The study was publis...
Source: Mutations -COVID-19 Oct 17, 2020 3 years ago
Mutations -COVID-19: Biologist and genomic experts from Duke University have identified a number of "silent" mutations in the roughly 30,000 letters of the virus's genetic code that helped it thrive once it made the leap to humans and possibly helped set the stage for the global pandemic. The subtle changes involved how the virus folded its RNA molecules within human cells....
COVID-19 Trends: In the beginning of the pandemic we had a lot of so called non-medical academics and government authorities trying to show off their prowess and ways that the pandemic ‘could be stopped ‘and their theories of flattening the curve with a variety for techniques such as social distancing of only between 1 to 3 meters, etc without first understanding a thing about the viru...
Vaccine-COVID-19: As more studies are showing that antibodies will ultimately only provide short term optimal protection of anything between 10 to 16 weeks and while at the same time other studies are also showing that many AAV (Adeno Associated Virus) vector RNA vaccines that are currently being developed and are in phase 3 trials might actually cause certain adverse effects https://www.thailandm...
Remdesivir: Interim results from the Solidarity Therapeutics Trial, coordinated by the World Health Organization, indicate that remdesivir, hydroxychloroquine, lopinavir/ritonavir and interferon regimens appeared to have little or no effect on 28-day mortality or the in-hospital course of COVID-19 among hospitalized patients.
The study results of the trial are under review for publi...
COVID-19 Winter: Researchers from the University of Utah in a new study has shown that individual particles of SARS-CoV-2 coronavirus undergo structural destabilization at relatively mild but elevated temperatures, strengthening the case for the COVID-19 resurgence in the coming winter.
The research findings are published on a preprint server and are currently being peer-reviewed. https:/...
Source: COVID-19 Research Oct 16, 2020 3 years ago
COVID-19 Research: A new international comparison study of the various coronaviruses and their effects on human host proteins and various human cellular pathways have revealed among many findings that the SARS-CoV-2 coronavirus protein Orf9b actually binds with the human host mitochondria protein TOM 70.
Orf9b of SARS-CoV-2 was found to be localized to mitochondria upon overexpression as ...
Vaccine News: Russia announced two months ago that its AAV (Adeno-associated virus) vector was approved for use despite lacking proper supporting study data and a proper phase 3 trial. In reality to date, the Sputnik V vaccine has been a flop as despite the Russian health authorities not admitting it, local Russian physicians and hospitals reported that that many vaccinated candidates not on...
COVID-19 Crisis: The current COVID-19 pandemic so far has been just a small speck compared of what is really to come and already sadly we can see the stupidity and incompetency of most governments and health agencies so far in terms of how the crisis has been handled in most European countries and the Americas( North and South America)
As of the 16th of October 2020, officially we have mo...
Source: Influenza 2020/2021 Oct 15, 2020 3 years ago
Influenza 2020/2021: Two different studies one by Chinese researchers and another led by British scientists show the high risk involved with sequential infection of influenza followed by COVID-19.
In the first study by Chinese scientist from State Key Laboratory of Virology, College of Life Sciences, Wuhan University-Wuhan, team shows that infection with the Influenza A virus or IAV actua...
Source: COVID-19 Neutralizing Antibodies Oct 15, 2020 3 years ago
COVID-19 Neutralizing Antibodies: A new study by researchers and immunologists from Westlake University, Zhejiang-China, Tsinghua University, Beijing-China and Southern University of Science and Technology, Shenzhen-China has found that human bivalent anti-spike antibodies are more effective in terms of viral neutralization and controlling a SARS-CoV-2 infection in humans.
The study team ...
Antibodies, Antibody test and ADE are a few words that has been in many news articles in the last few months as a result of the ongoing COVID-19 pandemic but many people still do not really have a proper perspective about what they are properly, hence we created this guide with the hope that it might help some of our readers. The summarized guide is not in detailed but just enough for individuals ...
Source: COVID-19 Intranasal Drugs Oct 15, 2020 3 years ago
COVID-19 Intranasal Drugs: North Carolina based clinical-stage biotechnology company Novan, Inc. that specializes in various nitric oxide based therapeutics has announced that its vitro studies involving its NITRICIL™ platform technology that uses berdazimer sodium has demonstrated antiviral effects against the SARS-CoV-2 coronavirus tha causes the COVID-19 disease.
Berdaz...
Source:Airborne SARS-CoV-2 Oct 15, 2020 3 years ago
Airborne SARS-CoV-2 virus can be detected by using dehumidifiers according to a new study by researchers from Maryland University.
The study team presented a simple approach that can potentially provide information about the prevalence of SARS-CoV-2 virus in the atmosphere at any location.
The study findings are published on a preprint server and are currently being peer reviewed. ...
Source: COVID-19 Research Oct 15, 2020 3 years ago
COVID-19 Research: A new study led by Dr Nanshan Zhong and Dr Ling Chen of the National Clinical Research Center for Respiratory Disease in China and Dr Jian Han, Faculty Investigator at the Hudson Alpha Institute in Alabama and founder of iRepertoire have identified a potent biomarker for predicting COVID-19 disease progression.
The study team used sequencing to characterize the immune s...
Source: COVID-19 Asymptomatic Oct 15, 2020 3 years ago
COVID-19 Asymptomatic: A new study led by scientist from Wuhan-China with support from National Institutes of Health, Bethesda-Maryland, have discovered that most COVID-19 asymptomatic individuals tend to have higher levels of lymphocytes especially CD4+ Cells indicating that these T Cells play a crucial role in the COVID-19 disease.
The research findings were published i...
COVID-19- Heart: Researchers from Columbia University Irving Medical Center-New York in a study involving retrospective analysis have found that individuals born with a heart defect who developed COVID-19 symptoms had a low risk of moderate or severe COVID-19 infection.
The study findings were published in the Journal of the American Heart Association. https://www.ahajournals.org/doi...
Source: Antibody Clinical Trial Oct 14, 2020 3 years ago
The Antibody Clinical Trial by Eli Lilly called ACTIV-3 clinical trial involving a combination of antibodies against COVID-19 has been suddenly halted over safety concerns yesterday. No details were furnished to the media or medical community.
A stoppage in trial would typically be because a patient or volunteer showed a serious side effect or became sick, but the company did not cla...
COVID-19 News: German researchers from the University Medical Center-Hamburg, Leibniz Institute for Experimental Virology, German Center for Infection Research, Institute of Neuropathology-Hamburg and the Medical Clinic and Polyclinic-Hamburg have in a new study discovered that the SARS-CoV-2 coronavirus has a high affinity manifesting replicative infection in the carotid arteries of the human hos...
Source: SARS-CoV-2 Antibodies Oct 14, 2020 3 years ago
SARS-CoV-2 Antibodies: A new research recently conducted by scientist from California Institute of Technology (Caltech) which can be described as the first properly detailed SARS-CoV-2 antibody study ever conducted so far has properly identified a series of antibodies that can actually be effective as therapeutics against the COVID-19 disease.
The research findings were published in the j...
.jpg)
